699 related articles for article (PubMed ID: 20579539)
21. Number and function of bone-marrow derived angiogenic cells and coronary flow reserve in women without obstructive coronary artery disease: a substudy of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Mohandas R; Sautina L; Li S; Wen X; Huo T; Handberg E; Chi YY; Merz CN; Pepine CJ; Segal MS
PLoS One; 2013; 8(12):e81595. PubMed ID: 24312563
[TBL] [Abstract][Full Text] [Related]
22. Incremental Value of Transthoracic Doppler Echocardiography-Assessed Coronary Flow Reserve in Patients With Suspected Myocardial Ischemia Undergoing Myocardial Perfusion Scintigraphy.
Gan LM; Svedlund S; Wittfeldt A; Eklund C; Gao S; Matejka G; Jeppsson A; Albertsson P; Omerovic E; Lerman A
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28420647
[TBL] [Abstract][Full Text] [Related]
23. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization.
Taqueti VR; Hachamovitch R; Murthy VL; Naya M; Foster CR; Hainer J; Dorbala S; Blankstein R; Di Carli MF
Circulation; 2015 Jan; 131(1):19-27. PubMed ID: 25400060
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
25. Renal function and coronary microvascular dysfunction in women with symptoms/signs of ischemia.
Mohandas R; Segal MS; Huo T; Handberg EM; Petersen JW; Johnson BD; Sopko G; Bairey Merz CN; Pepine CJ
PLoS One; 2015; 10(5):e0125374. PubMed ID: 25951606
[TBL] [Abstract][Full Text] [Related]
26. Mild renal dysfunction and long-term adverse outcomes in women with chest pain: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Mohandas R; Segal M; Srinivas TR; Johnson BD; Wen X; Handberg EM; Petersen JW; Sopko G; Merz CN; Pepine CJ
Am Heart J; 2015 Mar; 169(3):412-8. PubMed ID: 25728732
[TBL] [Abstract][Full Text] [Related]
27. Global Coronary Flow Reserve Measured During Stress Cardiac Magnetic Resonance Imaging Is an Independent Predictor of Adverse Cardiovascular Events.
Indorkar R; Kwong RY; Romano S; White BE; Chia RC; Trybula M; Evans K; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1686-1695. PubMed ID: 30409558
[TBL] [Abstract][Full Text] [Related]
28. Resting coronary velocity and myocardial performance in women with impaired coronary flow reserve: Results from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
Suppogu N; Wei J; Nelson MD; Cook-Wiens G; Cheng S; Shufelt CL; Thomson LEJ; Tamarappoo B; Berman DS; Samuels B; Azarbal B; Anderson RD; Petersen JW; Handberg EM; Pepine CJ; Merz CNB
Int J Cardiol; 2020 Jun; 309():19-22. PubMed ID: 32037132
[TBL] [Abstract][Full Text] [Related]
29. Brachial artery constriction during brachial artery reactivity testing predicts major adverse clinical outcomes in women with suspected myocardial ischemia: results from the NHLBI-sponsored women's ischemia Syndrome Evaluation (WISE) Study.
Sedlak TL; Johnson BD; Pepine CJ; Reis SE; Bairey Merz CN
PLoS One; 2013; 8(9):e74585. PubMed ID: 24058592
[TBL] [Abstract][Full Text] [Related]
30. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Arant CB; Wessel TR; Ridker PM; Olson MB; Reis SE; Delia Johnson B; Sharaf BL; Pauly DF; Handberg E; Zineh I; Sopko G; Kelsey SF; Noel Bairey Merz C; Pepine CJ
Clin Cardiol; 2009 May; 32(5):244-50. PubMed ID: 19452486
[TBL] [Abstract][Full Text] [Related]
31. Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.
Reis SE; Holubkov R; Conrad Smith AJ; Kelsey SF; Sharaf BL; Reichek N; Rogers WJ; Merz CN; Sopko G; Pepine CJ;
Am Heart J; 2001 May; 141(5):735-41. PubMed ID: 11320360
[TBL] [Abstract][Full Text] [Related]
32. Interaction of impaired coronary flow reserve and cardiomyocyte injury on adverse cardiovascular outcomes in patients without overt coronary artery disease.
Taqueti VR; Everett BM; Murthy VL; Gaber M; Foster CR; Hainer J; Blankstein R; Dorbala S; Di Carli MF
Circulation; 2015 Feb; 131(6):528-35. PubMed ID: 25480813
[TBL] [Abstract][Full Text] [Related]
33. Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.
Linke SE; Rutledge T; Johnson BD; Vaccarino V; Bittner V; Cornell CE; Eteiba W; Sheps DS; Krantz DS; Parashar S; Bairey Merz CN
Arch Gen Psychiatry; 2009 May; 66(5):499-507. PubMed ID: 19414709
[TBL] [Abstract][Full Text] [Related]
34. Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction ancillary study.
Rambarat CA; Elgendy IY; Handberg EM; Bairey Merz CN; Wei J; Minissian MB; Nelson MD; Thomson LEJ; Berman DS; Shaw LJ; Cook-Wiens G; Pepine CJ
Int J Cardiol; 2019 Feb; 276():8-13. PubMed ID: 30293664
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.
Arant CB; Wessel TR; Olson MB; Bairey Merz CN; Sopko G; Rogers WJ; Sharaf BL; Reis SE; Smith KM; Johnson BD; Handberg E; Mankad S; Pepine CJ;
J Am Coll Cardiol; 2004 Jun; 43(11):2009-14. PubMed ID: 15172405
[TBL] [Abstract][Full Text] [Related]
36. Left ventricular concentric remodelling and functional impairment in women with ischaemia with no obstructive coronary artery disease and intermediate coronary flow reserve: a report from the WISE-CVD study.
Park SM; Wei J; Cook-Wiens G; Nelson MD; Thomson L; Berman D; Handberg E; Petersen J; Anderson D; Pepine CJ; Merz CNB
Eur Heart J Cardiovasc Imaging; 2019 Aug; 20(8):875-882. PubMed ID: 30904924
[TBL] [Abstract][Full Text] [Related]
37. Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study.
Pepine CJ; von Mering GO; Kerensky RA; Johnson BD; McGorray SP; Kelsey SF; Pohost G; Rogers WJ; Reis SE; Sopko G; Bairey Merz CN;
J Womens Health (Larchmt); 2007 May; 16(4):481-8. PubMed ID: 17521251
[TBL] [Abstract][Full Text] [Related]
38. Stress Perfusion Coronary Flow Reserve Versus Cardiac Magnetic Resonance for Known or Suspected CAD.
Kato S; Saito N; Nakachi T; Fukui K; Iwasawa T; Taguri M; Kosuge M; Kimura K
J Am Coll Cardiol; 2017 Aug; 70(7):869-879. PubMed ID: 28797357
[TBL] [Abstract][Full Text] [Related]
39. Exercise treadmill testing using a modified exercise protocol in women with suspected myocardial ischemia: findings from the National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).
Lewis JF; McGorray S; Lin L; Pepine CJ; Chaitman B; Doyle M; Edmundowicz D; Sharaf BL; Merz CN;
Am Heart J; 2005 Mar; 149(3):527-33. PubMed ID: 15864243
[TBL] [Abstract][Full Text] [Related]
40. Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.
Olson MB; Krantz DS; Kelsey SF; Pepine CJ; Sopko G; Handberg E; Rogers WJ; Gierach GL; McClure CK; Merz CN;
Psychosom Med; 2005; 67(4):546-52. PubMed ID: 16046366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
